EPIX Therapeutics, Inc. (formerly Advanced Cardiac Therapeutics, Inc.) is a medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB. The Company's mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system.
EPIX’s technology is the only system in the world to leverage three unique capabilities: temperature sensing and feedback, low irrigation flow rates and high resolution electrogram attenuation.
EPIX’s flagship technology, the DiamondTemp™ ablation system, is a unique closed-loop,temperature-controlled system that provides physicians with improved feedback and control during an ablation procedure. The DiamondTemp system received CE Mark in Europe in 2017 and is limited to investigational use in the U.S.
EPIX Therapeutics was acquired by Medtronic in 2019.
Venture-stage investment in medical technology
STAGE CAPITAL TEAM